Industry pharmacist, technology expert

It took a trip to Canada, but Danielle Bancroft MPS went from community pharmacist to Product Manager and User Experience (UX) Designer at Fred...

Practice tips to reduce risks of polypharmacy

In a world of information overload, how can pharmacists prevent patients from falling into a medicine-induced downward spiral? Every day Australians swallow millions of...

Maintaining standards

The PSA’s WA Pharmacist of the Year Richard Smirk serves as the Clinical Advisor Pharmacy at the Australian Health Practitioner Regulation Agency (Ahpra) in Perth.

Infographic: Here’s how many people pharmacists have vaccinated

So far, community pharmacists have administered enough COVID-19 vaccine doses to fully vaccinate more than 1 million people. But that's just a number – here's what it really looks like.

Environmentally responsible inhaled respiratory treatments – Implications for practice

Ziqi is a regular at your pharmacy. She has popped in today to purchase a salbutamol pressurised metered dose inhaler (pMDI). You notice on her dispensing history that this will be her third in the last 4 weeks and she is overdue to have her repeat for her budesonide dry powder inhaler (DPI) filled.

The therapeutic potential of psychedelics

Thom, 37, a regular patient of the pharmacy, presents their venlafaxine repeat for dispensing. You know this has been prescribed for PTSD and ask how they have been going with their treatment. They disclose that their symptoms have been difficult to manage over the last few weeks and that they don’t feel like their medication has been working as well. Thom explains that a friend mentioned MDMA could be used for PTSD, and they’re now considering taking it to help them feel better.